Cancer in Crohnʼs Disease patients treated with infliximab: A long-term multicenter matched pair study

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNF  reduce colitis-associated colorectal carcinogenesis?

(2009) L. Biancone et al.   GUT

Infliximab for Inflammatory Bowel Disease in Denmark 1999–2005: Clinical Outcome and Follow-Up Evaluation of Malignancy and Mortality

(2008) Sarah Caspersen et al.   Clinical Gastroenterology and Hepatology

Hepatosplenic T cell lymphoma in inflammatory bowel disease

(2008) M. Shale et al.   GUT

Crohn's disease: factors associated with exposure to high levels of diagnostic radiation

(2008) A N Desmond et al.   GUT

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Survival in Danish patients with breast cancer and inflammatory bowel disease: A nationwide cohort study

(2007) Kirstine Kobbere Sgaard et al.   INFLAMMATORY BOWEL DISEASES